Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sültmann, H.
Right arrow Articles by Poustka, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sültmann, H.
Right arrow Articles by Poustka, A.
Clinical Cancer Research Vol. 11, 646-655, January 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Gene Expression in Kidney Cancer Is Associated with Cytogenetic Abnormalities, Metastasis Formation, and Patient Survival

Holger Sültmann1, Anja von Heydebreck2, Wolfgang Huber1, Ruprecht Kuner1, Andreas Buneß1, Markus Vogt1, Bastian Gunawan3, Martin Vingron2, Laszlo Füzesí3 and Annemarie Poustka1

1 Division of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany; 2 Department of Computational Molecular Biology, Max-Planck-Institute for Molecular Genetics, Berlin, Germany; and 3 Institute of Pathology, University of Göttingen, Göttingen, Germany

Requests for reprints: Holger Sültmann, Division of Molecular Genome Analysis, German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany. Phone: 49-6221-424705; Fax: 49-6221-42524705; E-mail: h.sueltmann{at}dkfz.de.

Current diagnosis of renal cancer consists of histopathologic examination of tissue sections and classification into tumor stages and grades of malignancy. Until recently, molecular differences between tumor types were largely unknown. To examine such differences, we did gene expression measurements of 112 renal cell carcinoma and normal kidney samples on renal cell carcinoma–specific cDNA microarrays containing 4,207 genes and expressed sequence tags. The gene expression patterns showed deregulation of complete biological pathways in the tumors. Many of the molecular changes corresponded well to the histopathologic tumor types, and a set of 80 genes was sufficient to classify tumors with a very low error rate. Distinct gene expression signatures were associated with chromosomal abnormalities of tumor cells, metastasis formation, and patient survival. The data highlight the benefit of microarrays to detect novel tumor classes and to identify genes that are associated with patient variables and tumor properties.

Key Words: renal cell carcinoma • gene expression




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
X. Wu, Y. Gong, J. Yue, B. Qiang, J. Yuan, and X. Peng
Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing
Nucleic Acids Res., June 1, 2008; 36(11): 3590 - 3599.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Jones and T. A. Libermann
Genomics of Renal Cell Cancer: The Biology Behind and the Therapy Ahead
Clin. Cancer Res., January 15, 2007; 13(2): 685s - 692s.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K.-i. Shioi, A. Komiya, K. Hattori, Y. Huang, F. Sano, T. Murakami, N. Nakaigawa, T. Kishida, Y. Kubota, Y. Nagashima, et al.
Vascular Cell Adhesion Molecule 1 Predicts Cancer-Free Survival in Clear Cell Renal Carcinoma Patients
Clin. Cancer Res., December 15, 2006; 12(24): 7339 - 7346.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Gong, J. Yue, X. Wu, X. Wang, J. Wen, L. Lu, X. Peng, B. Qiang, and J. Yuan
NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element
Nucleic Acids Res., December 4, 2006; 34(21): 6158 - 6169.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
T. Hothorn and P. Buhlmann
Model-based boosting in high dimensions
Bioinformatics, November 15, 2006; 22(22): 2828 - 2829.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Barth, R. Kuner, A. Buness, M. Ruschhaupt, S. Merk, L. Zwermann, S. Kaab, E. Kreuzer, G. Steinbeck, U. Mansmann, et al.
Identification of a Common Gene Expression Signature in Dilated Cardiomyopathy Across Independent Microarray Studies
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1610 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Arlt, W. Huber, U. Liebel, C. Schmidt, M. Majety, M. Sauermann, H. Rosenfelder, S. Bechtel, A. Mehrle, D. Bannasch, et al.
Functional Profiling: From Microarrays via Cell-Based Assays to Novel Tumor Relevant Modulators of the Cell Cycle
Cancer Res., September 1, 2005; 65(17): 7733 - 7742.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Jones, H. Otu, D. Spentzos, S. Kolia, M. Inan, W. D. Beecken, C. Fellbaum, X. Gu, M. Joseph, A. J. Pantuck, et al.
Gene Signatures of Progression and Metastasis in Renal Cell Cancer
Clin. Cancer Res., August 15, 2005; 11(16): 5730 - 5739.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.